Physician profile
Mackenzie Denton
NPI 1275159337
$1,834.88
in general payments reported to CMS, 2019-2025
17 companies · $714 in 2025
The $714 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29.49 · 2022: $20.80 · 2023: $148 · 2024: $923 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,784.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $553.76 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $280.40 | 2023-2024 | Airsupra, Farxiga, Breztri |
| Phathom Pharmaceuticals, INC. | $208.22 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $159.87 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $140.42 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Exact Sciences Corporation | $97.06 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $72.40 | 2024-2025 | |
| Amgen INC. | $64.41 | 2023-2025 | Otezla, Repatha, Repatha |
| Glaxosmithkline, LLC. | $57.79 | 2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $45.60 | 2020-2024 | |
| Pfizer INC. | $29.70 | 2025 | |
| Merck Sharp & Dohme LLC | $28.11 | 2020-2023 | Verquvo, Belsomra, Steglatro |
| Globus Medical, INC. | $27.40 | 2025 | Senza |
| Amryt Pharma Holdings Ltd | $20.80 | 2022 | |
| Philips North America LLC | $20.11 | 2024 | (Ck7) Extended Holter |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $14.50 | 2024 | Inspire |
| Insulet Corporation | $14.33 | 2024 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mackenzie Denton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.